Status:
COMPLETED
Can Mindfulness and Self-monitoring Improve Control Over Maladaptive Daydreaming?
Lead Sponsor:
University of Haifa
Conditions:
Internet-Based Intervention
Psychological Intervention
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Maladaptive daydreaming (MD) is a compulsive form of daydreaming that causes distress and functional impairment among tens of thousands of self-diagnosed sufferers. This is the first controlled treatm...
Detailed Description
Objective: Maladaptive daydreaming (MD) is a compulsive form of daydreaming that causes distress and functional impairment among tens of thousands of self-diagnosed sufferers. This is the first contro...
Eligibility Criteria
Inclusion
- Age above 18 years
- MD diagnosis
- Not being in any concurrent treatment for MD
- English fluent
- Daily access to the internet, and to a device with internet access
- Give informed consent to the study
- Respondents who reported being on a stable dose of medication for at least three months could take part in the study provided that they did not change their dosages while participating in the study.
Exclusion
- Age under 18 years
- No MD diagnosis
- In concurrent psychology therapy for MD
- Not fluent in English
- Not having a daily internet access
- Taking medication for less than three months
Key Trial Info
Start Date :
December 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
697 Patients enrolled
Trial Details
Trial ID
NCT05235243
Start Date
December 20 2018
End Date
February 28 2021
Last Update
February 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Haifa
Haifa, Israel, 3498838